Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Cynthia S Y Yeung"'
Autor:
Thomas Yau, David Tai, Stephen Lam Chan, Yi-Hsiang Huang, Su Pin Choo, Chiun Hsu, Tan To Cheung, Shi-Ming Lin, Wei Peng Yong, Joycelyn Lee, Thomas Leung, Tracy Shum, Cynthia S. Y. Yeung, Anna Yin-Ping Tai, Ada Lai Yau Law, Ann-Lii Cheng, Li-Tzong Chen
Publikováno v:
Liver Cancer (2022)
Background: Asia has a high burden of hepatocellular carcinoma (HCC) due to the high rates of chronic hepatitis B infection, and accounts for 70% of HCC cases globally. In the past 20 years, the systemic treatment landscape of advanced HCC has evolve
Externí odkaz:
https://doaj.org/article/40f6cf6d91f4490ba3706de915130645
Autor:
Connie H. M. Ho, Frank Cs. Wong, Kelvin K. K. Ng, Victor Lee, Siu-Ho Chok, W.C. Dai, Cynthia S Y Yeung, Chi-Leung Chiang, To-Wai Leung, Albert Cy Chan, Tan To Cheung, T Wong, Mai-Yee Luk, Chung Mau Lo, Ann-Shing Lee
Publikováno v:
Surgical Oncology. 28:228-235
Background This study compared outcomes of nonresectable hepatocellular carcinoma (HCC) who had transarterial chemoembolization (TACE) vs. stereotactic body radiation therapy (SBRT) after TACE (TACE + SBRT). Methods This was a retrospective study of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20c258da20f9778295769bc3e9a90dba
https://doi.org/10.1016/j.suronc.2019.01.006
https://doi.org/10.1016/j.suronc.2019.01.006
Autor:
Tracy Cy Shum, Yawen Dong, Thomas W. Leung, Wong Hoi She, Bryan Cho Wing Li, Vikki Tang, Cynthia S Y Yeung, Thomas Yau, Jeffrey Sum Lung Wong, Gerry Gin-Wai Kwok, Josephine Tsang, Ka Wing Ma, Ada Law, Anna Tai, Joanne Chiu, Tan To Cheung, Roland Leung
Publikováno v:
Cancers
Volume 13
Issue 9
Cancers, Vol 13, Iss 2002, p 2002 (2021)
Volume 13
Issue 9
Cancers, Vol 13, Iss 2002, p 2002 (2021)
Simple Summary The vascular endothelial growth factor and c-MET pathways are strongly implicated in hepatocellular carcinoma (HCC). Cabozantinib inhibits both pathways and has been approved in sorafenib-exposed advanced HCC (aHCC). We aimed to evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ca9ffb8b43e9325dbc8cffb9d3bf489
http://europepmc.org/articles/PMC8122581
http://europepmc.org/articles/PMC8122581
Autor:
Venus W Y Lee, Cynthia S Y Yeung, Kam Sze Tsang, Natalie S. M. Wong, Connie H. M. Ho, S. K. Ha, Mark ka heng Chan, Francis A. S. Lee, Chi-Leung Chiang, B. Wang
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Scientific Reports
Scientific Reports
This study aims at evaluating the symptom response, response duration, and toxicity of single dose palliative liver radiotherapy (RT) for symptomatic HCC patients. We reviewed unresectable HCC patients treated with palliative RT in our institution. E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b657b26ae1f53301e1052d92d762443d
https://doi.org/10.1038/s41598-020-58108-1
https://doi.org/10.1038/s41598-020-58108-1
Autor:
Yawen Dong, Tan To Cheung, Ada Law, Ka Wing Ma, Vikki Tang, Tracy Cy Shum, Roland Leung, Gin Wai Kwok, W.H. She, Thomas W.T. Leung, Anna Tai, Jeffrey Sum Lung Wong, Cynthia S Y Yeung, Joanne Wing Yan Chiu, Thomas Yau, Bryan Li, Wing Yan Josephine Tsang
Publikováno v:
Journal of Clinical Oncology. 39:e16179-e16179
e16179 Background: Cabozantinib is licensed for use as second- or third-line treatment for sorafenib-exposed advanced hepatocellular carcinoma (aHCC) based on the phase III CELESTIAL trial. However, its use in the post-immune checkpoint inhibitors (I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45d441696a4cb28a6be088075f6f37a9
https://doi.org/10.1200/jco.2021.39.15_suppl.e16179
https://doi.org/10.1200/jco.2021.39.15_suppl.e16179
Autor:
Venus W Y Lee, Cynthia S Y Yeung, Mark K. H. Chan, Oliver Blanck, Frank C.S. Wong, Connie H. M. Ho, Francis A. S. Lee, Chi-Leung Chiang
Publikováno v:
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 195(3)
We retrospectively evaluated the efficacy and safety of stereotactic body radiotherapy (SBRT) combined with trans-arterial chemoembolization (TACE) as initial therapy in Barcelona Clinic Liver Cancer (BCLC) system stage B–C hepatocellular carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25678f02f5eada579679bff5766711ef
https://pubmed.ncbi.nlm.nih.gov/30413833
https://pubmed.ncbi.nlm.nih.gov/30413833